nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Androgen receptor expression and breast cancer mortality in a population-based prospective cohort
|
Elebro, Karin |
|
2017 |
165 |
3 |
p. 645-657 |
artikel |
2 |
A pilot study of cabergoline for the treatment of metastatic breast cancer
|
Costa, Ricardo |
|
2017 |
165 |
3 |
p. 585-592 |
artikel |
3 |
A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer
|
Rugo, Hope S. |
|
|
165 |
3 |
p. 601-609 |
artikel |
4 |
A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer
|
Rugo, Hope S. |
|
2017 |
165 |
3 |
p. 601-609 |
artikel |
5 |
Association between lifestyle, menstrual/reproductive history, and histological factors and risk of breast cancer in women biopsied for benign breast disease
|
Arthur, Rhonda |
|
2017 |
165 |
3 |
p. 623-631 |
artikel |
6 |
A step-by-step oncoplastic breast conservation surgical atlas of reproducible dissection techniques and anatomically ideal incision placement
|
Mitchell, Sunny D. |
|
2017 |
165 |
3 |
p. 505-516 |
artikel |
7 |
Cognitive function and discontinuation of adjuvant hormonal therapy in older breast cancer survivors: CALGB 369901 (Alliance)
|
Bluethmann, Shirley M. |
|
2017 |
165 |
3 |
p. 677-686 |
artikel |
8 |
Detection of BRCA1 gross rearrangements by droplet digital PCR
|
Preobrazhenskaya, Elena V. |
|
2017 |
165 |
3 |
p. 765-770 |
artikel |
9 |
Different outcome in node-positive breast cancer patients found by axillary ultrasound or sentinel node procedure
|
Verheuvel, Nicole C. |
|
2017 |
165 |
3 |
p. 555-563 |
artikel |
10 |
Does biomarker information impact breast cancer patients’ preferences and physician recommendation for adjuvant chemotherapy?
|
Partridge, Ann H. |
|
2017 |
165 |
3 |
p. 545-553 |
artikel |
11 |
Erratum to: Pro-apoptotic effect of Δ2-TGZ in “claudin-1-low” triple-negative breast cancer cells: involvement of claudin-1
|
Geoffroy, Marine |
|
2017 |
165 |
3 |
p. 529 |
artikel |
12 |
From clinical trials to clinical practice: outcome of NSABP-B27 neoadjuvant chemotherapy regimen for high-risk early-stage breast cancer
|
Abdel-Razeq, Hikmat |
|
2017 |
165 |
3 |
p. 771-777 |
artikel |
13 |
Impact of the 21-gene recurrence score on outcome in patients with invasive lobular carcinoma of the breast
|
Kizy, Scott |
|
2017 |
165 |
3 |
p. 757-763 |
artikel |
14 |
Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer
|
Vriens, B. E. P. J. |
|
2017 |
165 |
3 |
p. 593-600 |
artikel |
15 |
Increasing utilization of regional nodal irradiation in elderly node-positive women and declining emphasis on demographic factors
|
Molitoris, Jason K. |
|
2017 |
165 |
3 |
p. 669-676 |
artikel |
16 |
In response to “outcomes of patients with inflammatory breast cancer treated by breast conserving surgery”: the argument against breast conservation and sentinel lymph node biopsy in IBC
|
Rosso, Kelly J. |
|
2017 |
165 |
3 |
p. 779-781 |
artikel |
17 |
Mammographic breast density decreases after bariatric surgery
|
Williams, Austin D. |
|
2017 |
165 |
3 |
p. 565-572 |
artikel |
18 |
New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth
|
Alshaker, Heba |
|
2017 |
165 |
3 |
p. 531-543 |
artikel |
19 |
Oncologists’ influence on receipt of adjuvant chemotherapy: does it matter whom you see for treatment of curable breast cancer?
|
Katz, Steven J. |
|
2017 |
165 |
3 |
p. 751-756 |
artikel |
20 |
Patterns and predictors of first and subsequent recurrence in women with early breast cancer
|
Geurts, Y. M. |
|
2017 |
165 |
3 |
p. 709-720 |
artikel |
21 |
Persistent impairments 3 years after (neo)adjuvant chemotherapy for breast cancer: results from the MaTox project
|
Hurtz, Hans-Jürgen |
|
2017 |
165 |
3 |
p. 721-731 |
artikel |
22 |
Predictive factors on outcomes in metaplastic breast cancer
|
Leyrer, C. Marc |
|
2017 |
165 |
3 |
p. 499-504 |
artikel |
23 |
Preoperative paravertebral blocks for the management of acute pain following mastectomy: a cost-effectiveness analysis
|
Offodile, Anaeze C. |
|
2017 |
165 |
3 |
p. 477-484 |
artikel |
24 |
Prevalence and spectrum of germline rare variants in BRCA1/2 and PALB2 among breast cancer cases in Sarawak, Malaysia
|
Yang, Xiaohong R. |
|
2017 |
165 |
3 |
p. 687-697 |
artikel |
25 |
Pro-apoptotic effect of Δ2-TGZ in “claudin-1-low” triple-negative breast cancer cells: involvement of claudin-1
|
Geoffroy, Marine |
|
2017 |
165 |
3 |
p. 517-527 |
artikel |
26 |
Prognostic impact of the inclusion of uPA/PAI-1 for adjuvant treatment decision-making in ER+/Her2− pN0 early breast cancers
|
Viala, Marie |
|
2017 |
165 |
3 |
p. 611-621 |
artikel |
27 |
Prognostic values of cancer associated macrophage-like cells (CAML) enumeration in metastatic breast cancer
|
Mu, Zhaomei |
|
2017 |
165 |
3 |
p. 733-741 |
artikel |
28 |
Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial
|
Nitz, Ulrike |
|
2017 |
165 |
3 |
p. 573-583 |
artikel |
29 |
Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial
|
Nitz, Ulrike |
|
2019 |
165 |
3 |
p. 573-583 |
artikel |
30 |
Response Letter
|
Brezezinska, M. |
|
2017 |
165 |
3 |
p. 783-784 |
artikel |
31 |
Reviewing the quality, health benefit and value for money of chemotherapy and targeted therapy for metastatic breast cancer
|
Pouwels, Xavier Ghislain Léon Victor |
|
2017 |
165 |
3 |
p. 485-498 |
artikel |
32 |
Risk of mortality of node-negative, ER/PR/HER2 breast cancer subtypes in T1, T2, and T3 tumors
|
Parise, Carol A. |
|
2017 |
165 |
3 |
p. 743-750 |
artikel |
33 |
The effect of 14-3-3ζ expression on tamoxifen resistance and breast cancer recurrence: a Danish population-based study
|
Thistle, Jake E. |
|
2017 |
165 |
3 |
p. 633-643 |
artikel |
34 |
The effects of physical activity and fatigue on cognitive performance in breast cancer survivors
|
Ehlers, Diane K. |
|
2017 |
165 |
3 |
p. 699-707 |
artikel |
35 |
Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patients
|
Hertz, Daniel L. |
|
2017 |
165 |
3 |
p. 659-668 |
artikel |
36 |
Whither surgical quality assurance of breast cancer surgery (surgical margins and local recurrence) after paterson
|
Bundred, N. J. |
|
2017 |
165 |
3 |
p. 473-475 |
artikel |